William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Form 497 WILLIAM BLAIR FUNDS
-
Haymaker Acquisition Corp. 4 Announces Closing of $230,000,000 Initial Public Offering, including Underwriters' Over-Allotment Option of $30,000,000
-
Form 485BPOS WILLIAM BLAIR FUNDS
-
EverQuote to Participate in Upcoming Investor Conferences
-
US new home sales fall, but trend remains strong
-
Haymaker Acquisition Corp. 4 (HYACU) Prices 20M Unit IPO at $10/unit
-
Haymaker Acquisition Corp. 4 Announces Pricing of $200 Million Initial Public Offering
-
AbbVie (ABBV) has 'near-term headwinds but stable longer-term growth' - William Blair
-
D.A. Davidson Strengthens Institutional Equities Team with Three Senior New Hires: Glen Sulam, Kevin DeThomas, and Alex Gamache
-
William Blair Starts Abbvie (ABBV) at Market Perform, 'we see near-term headwinds'
-
GTCR to Acquire Once For All from Warburg Pincus
-
Zoetis (ZTS) Gains After Analyst Says Initial Read of Competitor Labeling Suggests Trio Remains Differentiated
-
VSE Corp. (VSEC) Prices 2.48M Share Offering at $48.50/sh
-
VSE Corporation Prices Public Offering of Common Stock
-
Birch Lake Welcomes Joseph L. Robinson, II as Managing Director
-
VSE Corp. (VSEC) Announces Proposed Stock Offering
-
VSE Corporation Announces Public Offering of Common Stock
-
TPG (TPG) to Acquire Nextech for $1.4B
-
TPG to Acquire Leading Specialty Healthcare IT Platform Nextech
-
Form D/A William Blair: Non-US
-
Oxford Finance Announces the Closing of a $42 Million Credit Facility with Amino Health
-
William Blair Starts Tarsus Pharmaceuticals (TARS) at Outperform, 'Building an Eye Care Blockbuster'
-
William Blair Resumes Standex (SXI) at Outperform, ' Accelerating New Product Launches Across Fast Growth Market'
-
Leucid Bio Appoints Filippo Petti as Chief Executive Officer
-
TESSCO Announces Closing of Merger Transaction
-
GREENWOOD PROJECT ANNOUNCES NEW LEADERSHIP
-
Compass Diversified Announces Appointment of Geoffrey Feil as CEO of The Sterno Group
-
William Blair Downgrades Leslie's (LESL) to Market Perform, 'Shocking Prerelease Well Below Street'
-
Aravive to Participate in William Blair’s Innovator Series: Transitioning Biotech Breakthroughs to Commercial Success Being Held July 18, 2023
-
Aehr Reports Record Revenue and Profit for Fiscal 2023 and Guides for Over 50% Increase in Revenue for Fiscal 2024 on Strength from Semiconductor Wafer Level Test and Burn-in Demand
-
Tacton Announces Strategic Investment from Rubicon Technology Partners
-
Lyra Therapeutics to Present at William Blair Virtual Biotechnology Conference
-
Prime Capital Investment Advisors Forges Strategic Partnership with Abry Partners
-
Apnimed to Participate in the William Blair Virtual Conference: Transitioning Biotech Breakthroughs to Commercial Success
-
John LeVert Joins Solomon Partners as Managing Director in the Firm’s Consumer Retail Group
-
William Blair Names Michael Trimberger Chief Financial Officer
-
William Blair Resumes Kadant Inc. (KAI) at Outperform
-
Audax Private Equity Announces Agreement to Sell CorEvitas to Thermo Fisher Scientific
-
GTCR to Acquire Majority Stake in Worldpay
-
Hansa Biopharma to host conference call to provide half year results for January-June 2023 and a Business Update
-
Axsome Therapeutics Announces Closing of Public Offering of $225 Million of Shares of Common Stock
-
Form D/A William Blair Emerging
-
Form D/A William Blair Internatio
-
Form D/A William Blair Emerging
-
Form D/A William Blair Internatio
-
Axsome Therapeutics (AXSM) Prices 3M Share Offering at $75/sh
-
Axsome Therapeutics Announces Pricing of Public Offering of $225 Million of Shares of Common Stock
-
Snowflake (SNOW) adds to AI gains as Wall Street weighs in post summit
-
William Blair Resumes Snowflake Inc. (SNOW) at Outperform
-
THL explores sale of healthcare IT firm Nextech -sources

